Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2018: 95.39
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2018: 95.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2018.7(9): 3801-3810
DOI: https://doi.org/10.20546/ijcmas.2018.709.470


Can, acetylsalicylic acid as the most commonly used anti-aggregant prevent atrial fibrillation after coronary bypass surgery?
Eyupserhat Calik, Umit Arslan and Bilgehan Erkut*
Atatürk University, Medical Faculty, Department of Cardiovascular Surgery, Erzurum, Turkey
*Corresponding author
Abstract:

The present study investigated the effect of acetylsalicylic acid, an antiaggregant, on postoperative atrial fibrillation after coronary artery bypass surgery. Atrial fibrillation is a problem that affects mortality and morbidity rates after coronary surgery and prolongs hospital stay. Between January 2011 and October 2018, 722 coronary bypass surgery operations were performed. The patients were randomly divided into two groups as drug group (Group I; n=356) and control group (Group II; n=366). In Group I, the patients take to the acetylsalicylic acid (300 mg) without stopping up to 3 days before coronary bypass surgery. In Group II, the patients did not receive acetylsalicylic acid before surgery. Atrial fibrillation incidence rates were recorded retrospectively between 2 days and 4 weeks after the operation. Atrial fibrillation was seen in 21 (5.8%) patients in the Group I and 102 (27, 8 %) patients in the Group II had postoperative atrial fibrillation (p < 0.05). Intensive care unit and hospital stay were shorter in the drug group than the control group (p <0.05). In addition, hospital treatment costs were lower in the drug group (p <0.05). These results supported that acetylsalicylic acid is effective in preventing atrial fibrillation. Besides, acetylsalicylic acid treatment until operation day reduces hospital costs and length of stay in hospital, after the coronary artery bypasses grafting.


Keywords: Coronary artery bypass grafting, Atrial fibrillation, Anti-aggregant treatment, Cardiac surgery
Download this article as Download

How to cite this article:

Eyupserhat Calik, Umit Arslan and Bilgehan Erkut. 2018. Can, acetylsalicylic acid as the most commonly used anti-aggregant prevent atrial fibrillation after coronary bypass surgery?.Int.J.Curr.Microbiol.App.Sci. 7(9): 3801-3810. doi: https://doi.org/10.20546/ijcmas.2018.709.470